Functionalized liposomes for colorectal cancer therapy

Colorectal cancer (CRC) is one of the most common cancers. Many patients do not live for several years following their diagnosis, highlighting the urgent need for new treatment options, including new drug delivery methods. An effective strategy to increase the effectiveness of the treatment ofthis cancer is the use of a liposomal deliverysystem, which provides the possibility of providing hydrophobic and hydrophilic compounds with better biocompatibility and reduction of side effects by using several advantages, thus causing anti-cancer activity. Better tumor, drug accumulation is longer and they do not show any cytotoxic effect on normal cells. In this review, we will present nanoliposomes containing various compounds and ligands studied in CRC treatment. We will discuss on the benefits of liposomal administration in various forms, along with their effectiveness, specificity, and drug accumulation. Nanoliposome carriers have enormous potential to overcome the present constraints of cancer treatment, and the creation of this technology gives new possibilities in CRC treatment.